PRTA
Prothena Corp. Plc
NASDAQ · Healthcare · Biotechnology · IE
$8.58
+1.42%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 76.68x
- P/E 2027E
- —
- P/E 2028E
- 62.48x
- P/S forward
- 11.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.54x
- Price / sales
- 8.08x
- Price / cash flow
- -7.34x
Enterprise value
- Enterprise value
- $159.3M
- EV / sales
- 2.92x
- EV / EBITDA
- -3.87x
- EV / EBIT
- -2.54x
- Market cap
- $440.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026